How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/deficiency-of-testosterone-biosynthesis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Deficiency of testosterone biosynthesis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Deficiency of testosterone biosynthesis (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Deficiency of testosterone biosynthesis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Testosterone Cypionate	Testosterone Cypionate	Azurity	Androgen	Androgen receptor	1978-01-01
Testred	METHYLTESTOSTERONE	Bausch Health	Androgen [EPC]	Androgen receptor	1973-01-01
Androgel	TESTOSTERONE	Besins Hlthcare	Androgen [EPC]	Androgen receptor	1972-01-01
Xyosted (Autoinjector)	testosterone enantate	Endo	Androgen	Androgen receptor	1953-01-01
Testosteron	Testosteron	Gulhane School of Medicine		Corticosteroid-binding globulin, Alpha-synuclein, Lanosterol 14-alpha demethylase
Testosterone cypionate (200mg/3ml)	Testosterone cypionate (200mg/3ml)	Leticia Maria Defendi Barboza Marson	Androgenic steroid	Androgen receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Deficiency of testosterone biosynthesis
Azurity · 1 drug in Deficiency of testosterone biosynthesis
Bausch Health · 1 drug in Deficiency of testosterone biosynthesis
Besins Hlthcare · 1 drug in Deficiency of testosterone biosynthesis
Endo · 1 drug in Deficiency of testosterone biosynthesis
Gulhane School of Medicine · 1 drug in Deficiency of testosterone biosynthesis
Leticia Maria Defendi Barboza Marson · 1 drug in Deficiency of testosterone biosynthesis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Deficiency of testosterone biosynthesis:

Cite this brief

Drug Landscape (2026). Deficiency of testosterone biosynthesis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/deficiency-of-testosterone-biosynthesis. Accessed 2026-06-10.

Deficiency of testosterone biosynthesis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing